Baird’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Baird's VRTX Position: Q1 2015 in Review
Baird increased its Vertex Pharmaceuticals (VRTX) stake by 17% in Q1 2015, buying an estimated $123K and bringing the position to 7,118 shares worth $840K. The position accounts for 0.01% of the portfolio, ranked #803.
Baird first reported a position in VRTX in Q3 2014 and has held it in 3 quarters since. 479 funds tracked by Wall St. Rank hold VRTX as of Q1 2015.
- Baird held 7,118 shares of Vertex Pharmaceuticals worth $840K as of Q1 2015.
- Baird bought 1,027 Vertex Pharmaceuticals shares in Q1 2015, an estimated $123K.
- Vertex Pharmaceuticals made up 0.01% of Baird's portfolio in Q1 2015, its #803 holding.
- Baird first reported a position in Vertex Pharmaceuticals in Q3 2014 and has held it in 3 quarters since.
- 479 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2015.
Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.